Showing results (21-30 of 516) with videos related to
Sort By:
Pageof 52
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2009
Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxelC Sessa, D Tosi, L Viganò, et al.Cancer Cell|December 21, 2004
Antiangiogenic therapy: creating a unique "window" of opportunityMichelle I Lin, William C SessaCold Spring Harbor Perspectives in Biology|November 11, 2014
Inflammation and the blood microvascular systemJordan S Pober, William C SessaBritish Journal of Pharmacology|March 1, 1990
Release of a neutrophil-derived vasoconstrictor agent which augments platelet-induced contractions of blood vessels in vitroW C Sessa, K M MullaneCardiovascular Research|March 6, 2010
Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammationJohn H Chidlow, William C SessaNature Reviews. Immunology|September 26, 2007
Evolving functions of endothelial cells in inflammationJordan S Pober, William C SessaCirculation Research|April 1, 2017
Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular DiseaseJan R Kraehling, William C SessaAnalytical and Bioanalytical Chemistry|April 15, 2011
Determination of detection limits for SEM-EDS and m-FTIR analysis of artworkC Sessa, A Vila, J F GarcíaTrends in Pharmacological Sciences|February 1, 2003
Endothelial nitric oxide synthase: the Cinderella of inflammation?Giuseppe Cirino, Stefano Fiorucci, William C SessaThe Journal of Biological Chemistry|June 23, 1995
Functional analysis of the human endothelial nitric oxide synthase promoter. Sp1 and GATA factors are necessary for basal transcription in endothelial cellsR Zhang, W Min, W C SessaPageof 52